Hubei Guangji Pharmaceutical Co.,Ltd. Posted 28.1 Million Yuan Net Loss in First Half of 2023

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net loss of 28.1 million yuan in the first half of 2023, reversing a net profit of 23.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 343.9 million yuan in revenue, down 8.5% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 54.7%.